← Back to Search

Activity Monitoring for Spinal Cord Disease

N/A
Waitlist Available
Led By Ryan Spiker, M.D.
Research Sponsored by University of Utah
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Undergoing decompression surgery
Moderate to severe degenerative cervical pathology
Must not have
Unable or unwilling to comply with study protocol
Inability to ambulate
Timeline
Screening 3 weeks
Treatment Varies
Follow Up follow up visit at 6-months
Awards & highlights
No Placebo-Only Group

Summary

This trial will compare activity monitor results with standard of care question-based outcome measures for degenerative cervical myelopathy patients before and after treatment with decompression.

Who is the study for?
This trial is for adults over 18 with moderate to severe degenerative cervical myelopathy who are about to have decompression surgery. Participants need a smartphone capable of downloading the Fitbit app and must not have other injuries, disabilities, or activity limitations prior to their condition.
What is being tested?
The study aims to see if using a Fitbit activity monitor can give us as good or better information about physical function in patients with cervical myelopathy compared to standard question-based measures before and after they receive treatment.
What are the potential side effects?
Since this trial involves using an activity monitor like a Fitbit, there aren't direct medical side effects. However, participants may experience discomfort wearing the device or privacy concerns related to data collection.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am scheduled for surgery to relieve pressure in a body part.
Select...
I have moderate to severe neck spine issues.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
I am willing and able to follow the study rules.
Select...
I cannot walk on my own.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~follow up visit at 6-months
This trial's timeline: 3 weeks for screening, Varies for treatment, and follow up visit at 6-months for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Number of accrued steps in patients with degenerative cervical myelopathy with surgical decompression assessed by Fitbit activity level

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups
Experimental Treatment
Group I: InterventionExperimental Treatment1 Intervention
Pre-op appointment, patient will receive Fitbit device to track physical activity.

Find a Location

Who is running the clinical trial?

University of UtahLead Sponsor
1,141 Previous Clinical Trials
1,697,586 Total Patients Enrolled
Ryan Spiker, M.D.Principal InvestigatorUniversity of Utah
1 Previous Clinical Trials
608 Total Patients Enrolled

Media Library

Fitbit Clinical Trial Eligibility Overview. Trial Name: NCT04498806 — N/A
Cervical Myelopathy Research Study Groups: Intervention
Cervical Myelopathy Clinical Trial 2023: Fitbit Highlights & Side Effects. Trial Name: NCT04498806 — N/A
Fitbit 2023 Treatment Timeline for Medical Study. Trial Name: NCT04498806 — N/A
~19 spots leftby Aug 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top